Updated:
Synergy Life Science Partners
Synergy Life Science Partners, LP is a venture capital fund founded in 2006 by John Onopchenko, Richard Stack, M.D., and William Starling. Based in Portola...
Synergy Life Science Partners
Synergy Life Science Partners, LP is a venture capital fund founded in 2006 by John Onopchenko, Richard Stack, M.D., and William Starling. Based in Portola Valley, CA, the firm invests directly in private, early-stage medical device companies. Synergy Life Science Partners has made 26 investments, including EnCompass Technologies in May 2025.
General information
Firm type
Private Equity
Year founded
2006
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Frequently asked questions
Is Synergy Life Science Partners currently investing?
No. All available evidence points to the entity being inactive. Its web domain is for sale, and no recent investment activity, regulatory filings, or current team members have been found.
What was Synergy Life Science Partners' investment strategy?
Prior records indicate a focus on early-stage private equity in the life sciences sector, covering seed and start-up stages. Specific check sizes, fund structures, and portfolio companies are not known from surviving primary sources.
Who founded or ran Synergy Life Science Partners?
Management and founder names are not available. No primary sources — including a now-defunct website and absent LinkedIn presence — disclose the principals behind the firm.
What happened to Synergy Life Science Partners?
The firm's digital footprint has been reduced to a parked domain for sale. There is no publicly documented wind-down, acquisition, or rebrand, but it exhibits no operational signal in the current market.
Can I still purchase Synergy Life Science Partners' domain name?
Yes. The domain synergylsp.com is available for immediate purchase through HugeDomains for $8,595, with a 24-month payment plan option available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: